Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers (GUB-BCR-001)

University of Kansas

Status: Enrolling

Conditions: Bladder Cancer

Treatments: Other: Registry

Study type: Observational

Funder types: Other

Identifiers

NCT03413982

STUDY00141546

Details and patient eligibility

About

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
• Patients can participate in any additional research studies during the patients' participation within this protocol.

Exclusion criteria

• Patients who do not have presumed bladder cancer will not be eligible

Trial design

1,000 participants in 1 patient group

BC Patients

Description:

Patients with bladder cancer. This registry involves no intervention. Blood, urine, and tissue samples will be collected to be used for research.

Treatment:

Other: Registry